Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
10 practical priorities to prevent and manage serious allergic reactions: GA2LEN ANACare and EFA Anaphylaxis Manifesto.
Muraro A, de Silva D, Podesta M, Anagnostou A, Cardona V, Halken S, Smith P, Tanno LK, Turner P, Worm M, Alvaro-Lozano M, Arasi S, Asarnoj A, Barni S, Beyer K, Bilaver LA, Bird A, Bonaguro R, Brough HA, Chinthrajah RS, Cook EE, Demoulin C, Deschildre A, Dribin TE, Ebisawa M, Fernandez-Rivas M, Fiocchi A, Fleischer DM, Garrow E, Gerdts J, Giovannini M, Järvinen KM, Kelly M, Knol EF, Lack G, Lazzarotto F, Le TM, Leonard S, Lieberman J, Makris M, Mandelbaum L, Marchisotto MJ, Marino GA, Mori F, Nilsson C, Nowak-Wegrzyn A, Odemyr M, Oude Elberink HNG, Palosuo K, Patel N, Pier J, Poblete S, Rachid R, Rodríguez Del Río P, Said M, Sampson HA, Sánchez Sanz A, Schnadt S, Schultz F, Toniolo A, Upton JEM, Venter C, Vickery BP, Vlieg-Boerstra B, Wang J, Roberts G, Zuberbier T; GA2LEN ANACare Centres and EFA. Muraro A, et al. Among authors: dribin te. Clin Transl Allergy. 2024 Dec;14(12):e70009. doi: 10.1002/clt2.70009. Clin Transl Allergy. 2024. PMID: 39614094 Free PMC article. Review.
The use and implementation of omalizumab as food allergy treatment: Consensus-based guidance and Work Group Report of the Adverse Reactions to Foods Committee of the American Academy of Allergy, Asthma & Immunology.
Anagnostou A, Bird JA, Chinthrajah S, Dribin TE, Fleischer DM, Kim E, Nowak-Wegrzyn A, Rachid R, Shaker MS, Shreffler W, Sicherer S, Tam J, Vickery BP, Virkud YV, Wang J, Young M, Greenhawt M. Anagnostou A, et al. Among authors: dribin te. J Allergy Clin Immunol. 2024 Nov 22:S0091-6749(24)01177-1. doi: 10.1016/j.jaci.2024.09.031. Online ahead of print. J Allergy Clin Immunol. 2024. PMID: 39580718
Corrigendum to <'A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology'> <[Annals of Allergy, Asthma & Immunology 133 (2024) 286-94]>
Lieberman JA, Chu DK, Ahmed T, Dribin TE, Abrams EM, Anagnostou A, Blumenthal KG, Boguniewicz M, Chase NM, Golden DBK, Hartog NL, Heimall JR, Ho T, Lawrence MG, Khan DA, Minniear TD, Mustafa SS, Oppenheimer JJ, Phillips EJ, Ramsey A, Rider NL, Schneider L, Shaker MS, Spergel JM, Stone CA Jr, Stukus DR, Wang J, Greenhawt MJ. Lieberman JA, et al. Among authors: dribin te. Ann Allergy Asthma Immunol. 2024 Nov 2:S1081-1206(24)01630-2. doi: 10.1016/j.anai.2024.10.023. Online ahead of print. Ann Allergy Asthma Immunol. 2024. PMID: 39488779 No abstract available.
Epinephrine and anaphylaxis outcomes: Does timing matter?
Dribin TE, Greenhawt M. Dribin TE, et al. Ann Allergy Asthma Immunol. 2024 Nov;133(5):501-502. doi: 10.1016/j.anai.2024.08.029. Ann Allergy Asthma Immunol. 2024. PMID: 39488363 Free PMC article. No abstract available.
Management of Refractory Anaphylaxis: An Overview of Current Guidelines.
Pouessel G, Dribin TE, Tacquard C, Tanno LK, Cardona V, Worm M, Deschildre A, Muraro A, Garvey LH, Turner PJ. Pouessel G, et al. Among authors: dribin te. Clin Exp Allergy. 2024 Jul;54(7):470-488. doi: 10.1111/cea.14514. Epub 2024 Jun 12. Clin Exp Allergy. 2024. PMID: 38866583 Free PMC article. Review.
A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology.
Lieberman JA, Chu DK, Ahmed T, Dribin TE, Abrams EM, Anagnostou A, Blumenthal KG, Boguniewicz M, Chase NM, Golden DBK, Hartog NL, Heimall JR, Ho T, Lawrence MG, Khan DA, Minniear TD, Mustafa SS, Oppenheimer JJ, Phillips EJ, Ramsey A, Rider NL, Schneider L, Shaker MS, Spergel JM, Stone CA Jr, Stukus DR, Wang J, Greenhawt MJ. Lieberman JA, et al. Among authors: dribin te. Ann Allergy Asthma Immunol. 2024 Sep;133(3):286-294. doi: 10.1016/j.anai.2024.05.014. Epub 2024 Jun 5. Ann Allergy Asthma Immunol. 2024. PMID: 38848870 Free PMC article.
Preparing Patients for Oral Immunotherapy (PPOINT): International Delphi consensus for procedural preparation and consent.
Mack DP, Dribin TE, Turner PJ, Wasserman RL, Hanna MA, Shaker M, Tang MLK, Rodríguez Del Río P, Sobolewski B, Abrams EM, Anagnostou A, Arasi S, Bajowala S, Bégin P, Cameron SB, Chan ES, Chinthrajah S, Clark AT, Detjen P, du Toit G, Ebisawa M, Elizur A, Factor JM, Greiwe J, O'B Hourihane J, Hughes SW, Jones DH, Muraro A, Nowak-Wegrzyn A, Patel NB, Scurlock AM, Shah AN, Sindher SB, Tilles S, Vickery BP, Wang J, Windom HH, Greenhawt M. Mack DP, et al. Among authors: dribin te. J Allergy Clin Immunol. 2024 Jun;153(6):1621-1633. doi: 10.1016/j.jaci.2024.02.019. Epub 2024 Apr 8. J Allergy Clin Immunol. 2024. PMID: 38597862 Free PMC article.
Overview of Allergy and Anaphylaxis.
Dribin TE, Motosue MS, Campbell RL. Dribin TE, et al. Immunol Allergy Clin North Am. 2023 Aug;43(3):435-451. doi: 10.1016/j.iac.2022.10.009. Immunol Allergy Clin North Am. 2023. PMID: 37394251 Review.
31 results